SC 13G: COLLEGIUM PHARMACEUTICAL, INC
Ticker: COLL · Form: SC 13G · Filed: Nov 13, 2024 · CIK: 1267565
| Field | Detail |
|---|---|
| Company | Collegium Pharmaceutical, Inc (COLL) |
| Form Type | SC 13G |
| Filed Date | Nov 13, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by COLLEGIUM PHARMACEUTICAL, INC.
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Collegium Pharmaceutical, Inc (ticker: COLL) to the SEC on Nov 13, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ame of Issuer) Common stock, par value $0.001 per share (Title of Class of Securitie).
How long is this filing?
Collegium Pharmaceutical, Inc's SC 13G filing is 3 pages with approximately 933 words. Estimated reading time is 4 minutes.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 933 words · 4 min read · ~3 pages · Grade level 8.6 · Accepted 2024-11-13 17:13:28
Key Financial Figures
- $0.001 — ame of Issuer) Common stock, par value $0.001 per share (Title of Class of Securitie
Filing Documents
- coll.htm (SC 13G) — 25KB
- 0001085146-24-005627.txt ( ) — 27KB
(a)
ITEM 1(a). NAME OF ISSUER: COLLEGIUM PHARMACEUTICAL, INC
(b)
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
(a)
ITEM 2(a). NAME OF PERSON FILING: Principal Global Investors, LLC
(b)
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 801 Grand Avenue, Des Moines, IA 50392
(c)
ITEM 2(c). CITIZENSHIP: Delaware
(d)
ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common stock, par value $0.001 per share
(e)
ITEM 2(e). CUSIP NUMBER: 19459J104 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [X] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. As of the close of business on September 30, 2024: 1. Principal Global Investors, LLC (a) Amount beneficially owned: 1,745,663 (b) Percent of class: 5.42 (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: 0 (ii) shared power to vote or to direct the vote: 1,745,663 (iii) sole power to dispose or direct the disposition of: 0 (iv) shared power to dispose or to direct the disposition of: 1,745,663 ITEM 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has